학술논문
S-1 and oxaliplatin versus tegafur-uracil and leucovorin as post-operative adjuvant chemotherapy in patients with high-risk stage III colon cancer: updated 5-year survival of the phase III ACTS-CC 02 trial
Document Type
Article
Author
Source
In ESMO Open April 2021 6(2)
Subject
Language
ISSN
2059-7029